Alan G Baxter
Overview
Explore the profile of Alan G Baxter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jordan M, Gresle M, Gemiarto A, Stanley D, Smith L, Laverick L, et al.
Immunol Cell Biol
. 2024 Jun;
102(8):702-720.
PMID: 38877291
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system affecting predominantly adults. It is a complex disease associated with both environmental and genetic risk factors. Although over...
2.
Ng S, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, et al.
Nat Immunol
. 2024 Feb;
25(4):716.
PMID: 38360937
No abstract available.
3.
Lelliott E, Ramsbottom K, Dowling M, Shembrey C, Noori T, Kearney C, et al.
Front Immunol
. 2022 Jul;
13:931630.
PMID: 35874669
Cytotoxic lymphocytes are essential for anti-tumor immunity, and for effective responses to cancer immunotherapy. Natural killer cell granule protein 7 (NKG7) is expressed at high levels in cytotoxic lymphocytes infiltrating...
4.
Dinh X, Stanley D, Smith L, Moreau M, Berzins S, Gemiarto A, et al.
Sci Rep
. 2021 Dec;
11(1):23650.
PMID: 34880299
iNKT cells play a critical role in controlling the strength and character of adaptive and innate immune responses. Their unique functional characteristics are induced by a transcriptional program initiated by...
5.
Ng S, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, et al.
Nat Immunol
. 2020 Aug;
21(10):1205-1218.
PMID: 32839608
Immune-modulating therapies have revolutionized the treatment of chronic diseases, particularly cancer. However, their success is restricted and there is a need to identify new therapeutic targets. Here, we show that...
6.
Gresle M, Jordan M, Stankovich J, Spelman T, Johnson L, Laverick L, et al.
Life Sci Alliance
. 2020 Jun;
3(7).
PMID: 32518073
At least 200 single-nucleotide polymorphisms (SNPs) are associated with multiple sclerosis (MS) risk. A key function that could mediate SNP-encoded MS risk is their regulatory effects on gene expression. We...
7.
Too L, Yau B, Baxter A, McGregor I, Hunt N
Sci Rep
. 2019 Nov;
9(1):16189.
PMID: 31700009
Toll-like receptor (TLR) 2 and 4 signalling pathways are central to the body's defence against invading pathogens during pneumococcal meningitis. Whereas several studies support their importance in innate immunity, thereby...
8.
Wiede F, Brodnicki T, Goh P, Leong Y, Jones G, Yu D, et al.
Diabetes
. 2019 Apr;
68(6):1251-1266.
PMID: 30936146
Genome-wide association studies have identified as an important non-MHC gene for autoimmunity. Single nucleotide polymorphisms that reduce expression have been linked with the development of various autoimmune disorders, including type...
9.
Kling J, Jordan M, Pitt L, Meiners J, Thanh-Tran T, Tran L, et al.
Front Immunol
. 2018 Apr;
9:483.
PMID: 29616022
Natural killer T (NKT) cells are prominent innate-like lymphocytes in the liver with critical roles in immune responses during infection, cancer, and autoimmunity. Interferon gamma (IFN-γ) and IL-4 are key...
10.
Zeng B, Middelberg A, Gemiarto A, MacDonald K, Baxter A, Talekar M, et al.
J Clin Invest
. 2018 Feb;
128(5):1971-1984.
PMID: 29485973
Non-antigen-specific stimulatory cancer immunotherapies are commonly complicated by off-target effects. Antigen-specific immunotherapy, combining viral tumor antigen or personalized neoepitopes with immune targeting, offers a solution. However, the lack of flexible...